Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

BTNL2 helps protect hair follicles from immune attacks.

A patient with complete hair loss regrew all her hair using tofacitinib.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

Early combination therapy can effectively regrow hair in frontal fibrosing alopecia.

Ferulic acid helps wounds heal faster by reducing inflammation and promoting skin cell movement.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Formononetin may help protect the brain and treat neurological diseases.

Terminalia chebula fruit extract helps hair growth by reducing DHT and boosting hair cell activity.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Foxn1 helps skin cells mature by controlling a specific protein's activity.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

C.I. Acid Orange 3 caused cancer in female rats but not in male rats or mice.

Inactivating β-catenin is essential for chick retina regeneration.

Low ERCC3 gene activity is linked to non-pigmented hair growth.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Phospholipase C-δ1 is crucial for normal hair development.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.